Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Tissot, J.D."'
Publikováno v:
Transfusion clinique et biologique, vol. 27, no. 4, pp. 262-267
This essay aims to discuss some aspects of blood transfusion in the perspective of the changes that occurred over time as well as modifications of the paradigms that transformed the activities and the organization of blood transfusion services. Witho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::55a8cf0a45f675aeda6b812b8ee88557
https://serval.unil.ch/notice/serval:BIB_1C6D823D8534
https://serval.unil.ch/notice/serval:BIB_1C6D823D8534
Autor:
Garraud, O., Tissot, J.D.
Publikováno v:
Frontiers in medicine, vol. 5, pp. 84
Blood transfusion is made possible because, in most countries and organizations, altruistic individuals voluntarily, anonymously, and generously donate (without compensation) either whole blood or separated components that are then processed and dist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::be7fd39619018cf5924c3bf782c3460b
https://serval.unil.ch/notice/serval:BIB_B2306D81EAAA
https://serval.unil.ch/notice/serval:BIB_B2306D81EAAA
Publikováno v:
International journal of molecular sciences, vol. 18, no. 2, pp. E387
Blood banks use pathogen inactivation (PI) technologies to increase the safety of platelet concentrates (PCs). The characteristics of PI-treated PCs slightly differ from those of untreated PCs, but the underlying reasons are not well understood. One
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::eb929b2ce55e37275a1af77aa478f9ab
https://serval.unil.ch/notice/serval:BIB_33AFE8220365
https://serval.unil.ch/notice/serval:BIB_33AFE8220365
The European Hematology Association (EHA) Roadmap for European Hematology Research highlights major achievements in diagnosis and treatment of blood disorders and identifies the greatest unmet clinical and scientific needs in those areas to enable be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::e378e6bfd1d33b961a77fec041eaf995
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3101296
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3101296
Publikováno v:
Blood Reviews, vol. 28, no. 6, pp. 235-241
Since 1990, several techniques have been developed to photochemically inactivate pathogens in platelet concentrates, potentially leading to safer transfusion therapy. The three most common methods are amotosalen/UVA (INTERCEPT Blood System), riboflav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::e32c7d34f93e73ccaa3c6762df6f2918
https://serval.unil.ch/notice/serval:BIB_0DF65F1D66D1
https://serval.unil.ch/notice/serval:BIB_0DF65F1D66D1
Publikováno v:
International Journal of Molecular Sciences, vol. 11, no. 11, pp. 4601-4617
Millions of blood products are transfused every year; many lives are thus directly concerned by transfusion. The three main labile blood products used in transfusion are erythrocyte concentrates, platelet concentrates and fresh frozen plasma. Each of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::847203eb4a30834f1f72df208b8862ab
https://serval.unil.ch/resource/serval:BIB_AADFD6BAE81D.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_AADFD6BAE81D.P001/REF.pdf
Publikováno v:
In Transfusion clinique et biologique November 2014 21(4-5):262-263
Publikováno v:
In Transfusion clinique et biologique November 2014 21(4-5):262-262
Autor:
Breitschwerdt, B., Goeser, T., Tissot, J.D., Trendelenburg, M., Sis-Kluzik, J.M., Andrassy, K.
Publikováno v:
Infection; Sep1999, Vol. 27 Issue 4/5, p248-251, 4p
Publikováno v:
In Transfusion clinique et biologique September 2016 23(3):117-118